Dr. Kathleen (Cook) Uhl, OGD’s Director of the Office of Generic Drugs (OGD) will be going on an extended medical leave beginning on Monday, March 30, 2015. Cook has brought order to OGD, strengthened policy and procedure, oversaw the reorganization and elevation to Super Office of OGD and has OGD ready to spring forward into the GDUFA metric years. John Peters, M.D., Acting Director Office of Bioequivalence, will assume her duties during her absence.
We wish Cook the best and speediest of all recoveries and look forward to her return. Our thoughts are with her and we know yours are too!
